About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(TCF3/HLF)1Mlc
transgene insertion 1, Michael L Cleary
MGI:1889853
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
tg1
Tg(TCF3/HLF)1Mlc/0 involves: FVB/N MGI:2174883


Genotype
MGI:2174883
tg1
Allelic
Composition
Tg(TCF3/HLF)1Mlc/0
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• increase in mortality starting at around 6 months of age due to lymphoid tumors; 60% succumb to tumors with a mean latency of 10 months

neoplasm
• most lymphoid tumors are derived from T-cell lineage
• approximately 10% of tumors are derived from very early B-cell lineage

immune system
• at 4 and 6 weeks of age, thymuses contain about 30% of the cells as normal and at 8 and 10 weeks of age, thymocytes are reduced to 20 and 10%, respectively, of control levels
• most lymphoid tumors are derived from T-cell lineage
• premature involution
• thymus shows progressive accumulation of a T-lineage precursor population arrested at an early stage of maturation
• progressive decline of mature and immature T-cells
• thymocytes are reduced to 20 and 10% of control levels at 8 and 10 weeks of age, respectively
• significant reduction in the relative proportion of immature CD4+CD8+ thymocytes at 10 weeks of age
• by 24 weeks of age, essentially no double-positive cells are evident
• reduction is seen by 24 weeks of age
• reduction is seen by 24 weeks of age
• a proportion of CD4+ thymocytes remaining in the thymus at 24 weeks of age express a lower level of surface CD4 compared to the high levels present in control cells
• majority of CD4+ thymocytes at 24 weeks of age lack coexpression of CD3

hematopoietic system
• at 4 and 6 weeks of age, thymuses contain about 30% of the cells as normal and at 8 and 10 weeks of age, thymocytes are reduced to 20 and 10%, respectively, of control levels
• most lymphoid tumors are derived from T-cell lineage
• premature involution
• thymus shows progressive accumulation of a T-lineage precursor population arrested at an early stage of maturation
• progressive decline of mature and immature T-cells
• thymocytes are reduced to 20 and 10% of control levels at 8 and 10 weeks of age, respectively
• significant reduction in the relative proportion of immature CD4+CD8+ thymocytes at 10 weeks of age
• by 24 weeks of age, essentially no double-positive cells are evident
• reduction is seen by 24 weeks of age
• reduction is seen by 24 weeks of age
• a proportion of CD4+ thymocytes remaining in the thymus at 24 weeks of age express a lower level of surface CD4 compared to the high levels present in control cells
• majority of CD4+ thymocytes at 24 weeks of age lack coexpression of CD3

endocrine/exocrine glands
• at 4 and 6 weeks of age, thymuses contain about 30% of the cells as normal and at 8 and 10 weeks of age, thymocytes are reduced to 20 and 10%, respectively, of control levels
• thymocytes are reduced to 20 and 10% of control levels at 8 and 10 weeks of age, respectively
• most lymphoid tumors are derived from T-cell lineage
• premature involution





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory